Hi guys,
Book to price is above 50 for REC.
That is amongst the high fifures on the market.
In addition, I reckon, $150 mil MC would be a bit high for a pharma company which is in its early clinical stage.
How do you justify these, guys.
Thanks
Hi guys,Book to price is above 50 for REC. That is amongst the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.8¢ |
Change
0.003(0.65%) |
Mkt cap ! $112.0M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 39.0¢ | 38.0¢ | $4.167K | 10.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24610 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 49817 | 1 |
View Market Depth
| Last trade - 15.44pm 31/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |